BHLHE40 and myeloid sarcoma: Both Bhlhe40 and GM-CSF have been shown to be indispensable for EAE induction, since deficiency in either factor confers protection against EAE (7, 8, 10–12), and elevated GM-CSF levels have been correlated with the active phase of MS (63).